Better Buy: Vertex Pharmaceuticals vs. Galapagos
Which stock wins in a matchup between these two successful biotechs?
Galapagos
GLPG
GLPG
$161.68
-$0.51
-0.3%
BATS BZX Real Time Price as of October 16, 2019, 4:00 p.m. EDT
View Interactive GLPG Charts
GALAPAGOS NV SPON ADR REPR 1 ORD SHS
News & Analysis: Galapagos
Here's Why Galapagos NV Rose 34.5% in July
The Belgian biopharma bagged $5.1 billion from its most important partner.
Galapagos NV (GLPG) Q2 2019 Earnings Call Transcript
GLPG earnings call for the period ending June 30, 2019.
Gilead's Galapagos Deal: What It Means for Investors
Here's what Gilead's getting with its $5.1 billion Galapagos collaboration.
3 Soaring Biotech Stocks With More Fuel in the Tank
Despite already massive gains this year, shares of these drugmakers could keep on climbing.
What Happened in the Stock Market Today
From failed takeover talks to a massive new partnership, see why these stocks were on the move on a quiet day for the broader markets.
Why Galapagos NV Stock Is Soaring Today
Gilead Sciences decided to inject $5.1 billion into its R&D partner Galapagos NV over the weekend.
Here's Why Galapagos NV Stock Rose 13.4% in June
The good news keeps rolling in for this Belgian pharma.
Better Buy: Vertex Pharmaceuticals vs. Galapagos
Two rising biotech stocks. One clear long-term winner.
Galapagos NV (GLPG) Q1 2019 Earnings Call Transcript
GLPG earnings call for the period ending March 31, 2019.
